三個皮匠報告
政策庫
new
付費
搜索

百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究-行業數據

百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究
基于新一代 linker-payload 技術產品：基于新一代 linker-payload 技術，公司開發了新的linker-payload 的產品雙抗 ADC BL-B16D1 以及單抗 ADC BL-M17D1。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?09KB 圖片尺寸：2316*869
同報告圖片
 / 44
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第1頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第2頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第3頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第4頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第5頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第6頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第7頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第8頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第9頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第10頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第11頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第12頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第13頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第14頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第15頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第16頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第17頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第18頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第19頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第20頁
fCDoja/nianlkI3np7AgfCDpnbbngrkgfCDlhazlj7ggfCDlhajnkIPmnIDpq5jnoJTlj5HnirbmgIEgfCDkuK3lm73mnIDpq5jnoJTlj5HnirbmgIEgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQ2V0dXhpbWFiIHNhcm90YWxvY2FuIHwgRUdGUiBBREMgfCBBc3B5cmlhbiBUaGVyYXBldXRpYyB8IOaJueWHhuS4iuW4giB8IOaXoOeUs+aKpSB8CnwgTVJHLTAwMyB8IEVHRlIgQURDIHwg5LmQ5pmu55Sf54mpIHwgTkRBIHwgTkRBIHwKfCBTWVMtNjAxMCB8IEVHRlIgQURDIHwg55+z6I2v6ZuG5ZuiIHwg5Li05bqK5LiJ5pyfIHwg5Li05bqK5LiJ5pyfIHwKfCBBQlQtNDE0IHwgRUdGUiBBREMgfCDoib7kvK/nu7QgfCDkuLTluorkuInmnJ8gfCDkuLTluorkuInmnJ8gfAp8IEMyMjUtSUxTLURPWCB8IEVHRlIgQURDIHwgVW5pdmVyc2l0YXRzU3BpdGFscyBCYXNlbCB8IOS4tOW6iuS6jOacnyB8IOaXoOeUs+aKpSB8CnwgRS1FRFYtRDY4MiB8IEVHRlIgQURDIHwgRW5nZW5laWMgTHRkIHwg5Li05bqK5LqM5pyfIHwg5peg55Sz5oqlIHwKfCBCQi0xNzA1IHwgRUdGUiBBREMgfCDnmb7lipvlj7jlurcgfCDkuLTluorkuIDmnJ8gfCDkuLTluorkuIDmnJ8gfAp8IERYQzAwNEEgfCBFR0ZSIEFEQyB8IOWkmuemp+eUn+eJqSB8IOS4tOW6iuS4gOacnyB8IOS4tOW6iuS4gOacnyB8CnwgSExYLTQyIHwgRUdGUiBBREMgfCDlpI3lro/msYnpnJYgfCDkuLTluorkuIDmnJ8gfCDkuLTluorkuIDmnJ8gfAp8IFlMLTIyMSB8IEVHRlIgQURDIHwg5a6c6IGU55Sf54mpIHwg5Li05bqK5LiA5pyfIHwg5Li05bqK5LiA5pyfIHwKfCBMb3NhdHV4aXp1bWFiIHZlZG90aW4gfCBFR0ZSIEFEQyB8IOiJvuS8r+e7tCB8IOS4tOW6iuS4gOacnyB8IOaXoOeUs+aKpSB8CnwgQUJCVi02MzcgfCBFR0ZSIEFEQyB8IOiJvuS8r+e7tCB8IOS4tOW6iuS4gOacnyB8IOaXoOeUs+aKpSB8CnwgQUxLLTIwMiB8IEVHRlLDl2MtTWV0IEFEQyB8IOWuiemihuenkSB8IOS4tOW6iuS4gOacnyB8IOS4tOW6iuS4gOacnyB8CnwgQVpEOTU5MiB8IEVHRlLDl2MtTWV0IEFEQyB8IOmYv+aWr+WIqeW6tyB8IOS4tOW6iuS4gOacnyB8IOS4tOW6iuS4gOacnyB8CnwgRE0tMDA1IHwgRUdGUsOXYy1NZXQgQURDIHwg5aSa546b5Yy76I2vIHwg5Li05bqK5LiA5pyfIHwg5Li05bqK5LiA5pyfIHwKfCBLWS0wMzAxIHwgRUdGUsOXYy1NZXQgQURDIHwg56eR5byI6I2v5LiaIHwg5Li05bqK5LiA5pyfIHwg5Li05bqK5LiA5pyfIHwKfCBGUEktMjA2OCB8IEVHRlLDl2MtTWV0IEFEQyB8IEZ1c2lvbiB8IOS4tOW6iuS4gOacnyB8IOaXoOeUs+aKpSB8CnwgQkNHLTAxMSB8IEVHRlLDl1RST1AyIEFEQyB8IOeZvuWlpei1m+Wbvi/lpJrnjpvljLvoja8gfCDkuLTluorkuIDmnJ8gfCDkuLTluorkuIDmnJ8gfAp8IElCSS0zMDAxIHwgRUdGUsOXQjdIMyBBREMgfCDkv6Hovr7nlJ/niakgfCDkuLTluorkuIDmnJ8gfCDkuLTluorkuIDmnJ8gfAp8IE0tMTIzMSB8IEVHRlLDl01VQzEgQURDIHwgRW5kIFNlcm9ubyB8IOS4tOW6iuS4gOacnyB8IOaXoOeUs+aKpSB8CgrotYTmlpnmnaXmupDvvJroja/muKHmlbDmja7vvIzlm73mipXor4HliLjor4HliLjnoJTnqbbmiYDvvIzms6jvvJrnu5/orqHml7bpl7TmiKrmraIyMDI15bm0NeaciDEw5pel
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第21頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第22頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第23頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第24頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第25頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第26頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第27頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第28頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第29頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第30頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第31頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第32頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第33頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第34頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第35頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第36頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第37頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第38頁
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8ICB8IDIwMjVFIHwgMjAyNkUgfCAyMDI3RSB8IDIwMjhFIHwgMjAyOUUgfCAyMDMwRSB8IDIwMzFFIHwgMjAzMkUgfCAyMDMzRSB8IDIwMzRFIHwKfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfCAtLS0gfAp8ICoq5oC75pS25YWl77yI5Lq/5YWD77yJKiogfCAyMi41IHwgMjcuMiB8IDI1LjcgfCA0OC4zIHwgMTU5LjEgfCAxOTEuNCB8IDIyMS41IHwgMjMxLjEgfCAyMjcuOCB8IDIxNy4wIHwKfCAqKnlveSoqIHwgLTYxJSB8IDIxJSB8IC02JSB8IDg4JSB8IDIzMCUgfCAyMCUgfCAxNiUgfCA0JSB8IC0xJSB8IC01JSB8CnwgKipFR0ZSIHggSEVSMyDlj4zmipcgQURDIEJMLUIwMUQx77ya5Zu95YaF5biC5Zy6KiogfCAwLjAgfCAyLjcgfCAxMi43IHwgMjYuNyB8IDQ2LjIgfCA2MS43IHwgNjkuOSB8IDY5LjIgfCA2Ny43IHwgNjQuMSB8CnwgKipFR0ZSIHggSEVSMyDlj4zmipcgQURDIEJMLUIwMUQx77ya576O5Zu95biC5Zy65YiG5oiQKiogfCAwLjAgfCAwLjAgfCAwLjAgfCAyLjkgfCA0LjYgfCAxNi44IHwgMzEuOCB8IDQzLjMgfCA0My41IHwgNDQuMSB8CnwgKipFR0ZSIHggSEVSMyDlj4zmipcgQURDIEJMLUIwMUQx77ya5qyn5rSy5biC5Zy65YiG5oiQKiogfCAwLjAgfCAwLjAgfCAwLjAgfCAwLjUgfCAwLjkgfCAzLjEgfCA1LjkgfCA4LjAgfCA4LjEgfCA4LjIgfAp8ICoqRUdGUiB4IEhFUjMg5Y+M5oqXIFNJLUIwMDEqKiB8IDAuMCB8IDEuOSB8IDcuNyB8IDEwLjMgfCAxMi45IHwgMTQuMCB8IDE2LjQgfCAxMy4zIHwgMTEuMiB8IDEwLjYgfAp8ICoqSEVSMiBBREMgQkwtTTA3RDEqKiB8IDAuMCB8IDAuMCB8IDAuMSB8IDIuNiB8IDUuMiB8IDYuMyB8IDcuOSB8IDcuNSB8IDcuNSB8IDcuMSB8CnwgKirljJboja/liLbliYIqKiB8IDMuNSB8IDMuNiB8IDMuNiB8IDMuNyB8IDMuOCB8IDMuOSB8IDMuOSB8IDQuMCB8IDQuMSB8IDQuMiB8CnwgKirkuK3oja/liLbliYIqKiB8IDEuNSB8IDEuNSB8IDEuNiB8IDEuNiB8IDEuNiB8IDEuNyB8IDEuNyB8IDEuNyB8IDEuOCB8IDEuOCB8CnwgKirlkIjkvZzph4znqIvnopEqKiB8IDE3LjUgfCAxNy41IHwgMCB8IDAgfCA4NCB8IDg0IHwgODQgfCA4NCB8IDg0IHwgNzcgfAoK6LWE5paZ5p2l5rqQ77ya5Zu95oqV6K+B5Yi456CU56m25omA77yM5rOo77ya5LiK6L+w5pS25YWl5Z2H5Li657uP6L+H6aOO6Zmp5L+u5q2j5ZCO55qE6ZSA5ZSu5pS25YWl77yb6ICD6JmR5YiwIEVHRlIgeCBIRVIzIOWPjOaKlyBBREMgQkwtQjAxRDEg5Zu95YaF6by75ZK955mMIDMg5pyf5Li05bqK5LqOIDIwMjQg5bm0IDMg5pyI5ZCv5Yqo77yM6aKE6K6hIDIwMjUg5bm05LiL5Y2K5bm05LiK5biC44CC
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第39頁
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
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第40頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第41頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第42頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第43頁
fCDmioDmnK8gfCDnrKzkuIDkuInlhbEgfCDnmb7liKnlpKnmgZIgfCDmgZLnkZ7ljLvoja8gfCDnmb7lpaXms7AgfCDmraPlpKflpKnmmbQgfCDnn7Poja/pm4blm6IgfCDnmb7mtY7npZ7lt54gfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IOS7o+ihqOiNr+eJqSB8IERTLTgyMDEgfCBCTEUtQjAxRDEgfCBTSFItQTE4MTEgfCBCQVQ4MDkgfCBUUUIyMTAyIHwgLyB8IEI3LUgzIEFEQyB8Cnwg5Lqn5ZOB6Z2254K5IHwgSEVSMiB8IEVHRlLDl0hFUjMgfCBIRVIyIHwgQjctSDMgfCBIRVIyIOWPjOaKlyB8IC8gfCBCNy1IMyB8Cnwg5o6l5aS05oqA5pyvIHwg5Lyg57ufIE1DIOaOpeWktCB8IOe7j+aUuemAoOmFuOaApyBNQyDmjqXlpLQgfCDkvKDnu58gTUMg5o6l5aS0IHwg5Lyg57ufIE1DIOaOpeWktCB8IOS8oOe7nyBNQyDmjqXlpLQgfCDkvKDnu58gTUMg5o6l5aS0IHwg5Lyg57ufIE1DIOaOpeWktCB8CnwgTGlua2VyIHwgTUMtR0dGRyB8IE1DLUdHRkcgfCBNQy1HR0ZHIHwgUEVHIOS/rumlsCBWQy1QQUJDIHwgTUMtR0dGRyB8IE1DLUdHRkcgfCBNQy3nu4/kv67ppbAgR0dGRyB8Cnwg6YeK5pS+5Y2V5YWDIHwgR0dGRyB8IEdHRkcgfCBHR0ZHIHwgVkMtUEFCQyB8IEdHRkcgfCBHR0ZHIHwgR0dGRyB8Cnwg5Y+v5ZCm6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwg5Y+v6KOC6KejIHwKfCDmr5LntKDnsbvlnosgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfCDmi5PmiZHlvILmnoTphbYgSSDmipHliLbliYIgfAp8IOavkue0oCB8IERYZCB8IOe7j+aUuemAoCBEWGQgfCDnu4/mlLnpgKAgRFhkIHwg57uP5pS56YCgIERYZCB8IOawmOS7oyBEWGQgfCDnu4/mlLnpgKAgRFhkIHwg57uP5pS56YCgIERYZCB8CnwgREFSIHwgNy43IHwgOCB8IDUuNyB8IC8gfCAvIHwgLyB8IC8gfAoK6LWE5paZ5p2l5rqQ77ya5ZCE5YWs5Y+45a6Y572R77yM5ZCE5YWs5Y+45LiT5Yip77yM5Zu95oqV6K+B5Yi46K+B5Yi456CU56m25omA77yM5rOo77ya5oqA5pyv6Lev57q/57uG6IqC5Li76KaB5p2l6Ieq55u45YWz5YWs5Y+45bey5YWs5byA5LiT5Yip77yM5LiN5Luj6KGo5LiO6KGo5qC85Lit5Luj6KGo6I2v54mp5a6M5YWo5LiA6Ie0
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第44頁
百利天恒其他基于新一代linker-payload技術ADC藥物布局及已開展臨床研究_第45頁
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
所屬報告： 百利天恒-公司研究報告-雙抗ADC引領國際化征程ADC+多抗龍頭崛起-250514（38頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站